NL-OMON37415已完成不适用
An open-label, multiple-dose, two-treatment period study to evaluate the effect of oral BAF312 on the pharmacokinetics and pharmacodynamics of a monophasic oral contraceptive in healthy female volunteers. - CBAF312A2121 (CS0175)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- ovartis
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Woman between the ages of 18 and 40 years and a non-smoker. BMI between 18
- •and 30, with a minimum weight of 50 kg.
排除标准
- •Clinical significant abnormalities at medical research
研究者
相似试验
进行中（未招募）
不适用
Study to evaluate the effect of oral BAF312 on a monophasic oral contraceptive in healthy female volunteersEUCTR2011-006043-30-NLovartis Pharma Services AG24
已完成
不适用
An open-label, multiple-dose, sequential, 2 treatment period study to evaluate the effect of QBW251 on the pharmacokinetics and pharmacodynamics of a monophasic oral contraceptive in pre-menopausal healthy female volunteersCFmucoviscidosis1004078910013326NL-OMON40637ovartis47
进行中（未招募）
不适用
A two-staged, open label, single dose, two period, two-sequence,crossover study to compare the bioavailability of 2 mg GlycopyrroniumBromide from a new oral solution (2 mg/5 ml) (Test Product) with thatof 2 mg Glycopyrronium Bromide from Cuvposa (1 mg/5 ml) Solution(Reference product) in at least 36 healthy male and female subjectsunder fasting conditions.Sialorrhoea (chronic pathological drooling)EUCTR2013-002557-30-Outside-EU/EEAProveca Ltd36
已完成
不适用
Study to evaluate the safety and pharmacokinetics after co-administration of UIC201601 and UIC201602Endocrine, nutritional and metabolic diseasesKCT0007411Korea United Pharm40
进行中（未招募）
1 期
Clinical trial in Healthy Volunteers to test Valsartan PharmacokineticsHypertensionEUCTR2016-004323-23-Outside-EU/EEAovartis86